Trending...
- World Sleep Day, why do we celebrate?
- Fridge Art Fair New York City May 2023
- California: Governor Newsom Announces Historic Transformation of San Quentin State Prison
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced record revenues for 2022. Revenue growth in 2022 was dramatic, increasing over 60% over 2021 revenue.
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
- San Jose: : San José's Chief Building Official Chu Chang Honored as California Building Official of the Year
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Array Technologies, Inc. (ARRY) on Behalf of Investors
- Sip Social Co. Partners With Apé Canada For Supply Of Piaggio Apé's
- California Woman Battling Alopecia Launches Online Wig, Hair Accessories Store
- Orange County Business Journal Ranks Snell & Wilmer in the Top 10 Largest Law Firms in Orange County
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
Filed Under: Business
0 Comments
Latest on The Californer
- Sortium Joins UC Berkeley's Blockchain Xcelerator Program
- Taylor Marsh Leads the Way in Spiritual Mentoring in California
- California Storm Response and Recovery Update
- Children's Book Author and Artist Karen Winnick Was Featured Reader for Mutt-i-grees® Curriculum in March
- San Jose: Media Advisory: Cannabis Equity Business Academy Applications Now Being Accepted
- 100 YEARS OF CUNARD CAPTURED IN TIME
- SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Tupperware Brands Corporation with Losses of $100,000 to Contact the Firm
- Eddie Turner is Recognized as the #9 Motivational Speaker in the World By Global Gurus!
- SoCalGas Exceeds State Goal for 30th Consecutive Year, Purchasing Nearly 43% of all Goods and Services from Diverse Businesses Last Year
- Fabric Launches Origin Data Service for Content Owners
- Rokid Unveils Rokid Max AR Glasses With Premium MAX-Theater Experience
- Dan Devon announces pre-save for new alternative single "moonlit"
- California: Governor Newsom Announces Appointments 3.21.23
- Shareholder Alert: Robbins LLP Informs Investors of Class Action Against United Natural Foods, Inc. (UNFI)
- What's for dinner? We'll help you decide
- Critical Runway Lighting Upgrades Key to Electrical Improvements Planned at Long Beach Airport
- Southeast Ventura County YMCA National Day of Prayer Breakfast Seeks Sponsors
- RE/MAX Signature Earns Top Regional Award
- Prime Healthcare Celebrates Patient Safety Excellence Recognition from Healthgrades
- Long Beach to Offer Free Youth Recreation Program in Local Parks During School Spring Break April 10-14